Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
euroPLX 90 LisboneuroPLX 90 Lisbon
Not Confirmed
Not Confirmed
02-03 March, 2026
BIO CEO & InvestorBIO CEO & Investor
Not Confirmed
Not Confirmed
02-03 March, 2026
Clinical OutsourcingClinical Outsourcing
Not Confirmed
Not Confirmed
03-04 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
euroPLX 90 LisboneuroPLX 90 Lisbon
Industry Trade Show
Not Confirmed
02-03 March, 2026
BIO CEO & InvestorBIO CEO & Investor
Industry Trade Show
Not Confirmed
02-03 March, 2026
Clinical OutsourcingClinical Outsourcing
Industry Trade Show
Not Confirmed
03-04 March, 2026
Digital content

24 Feb 2026
// BLOOMBERG
https://www.bloomberg.com/news/articles/2026-02-24/pfizer-secures-china-rights-to-obesity-drug-in-495-million-deal

10 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-global-licensing-and-collaboration-agreement-for-metabolic-disease-portfolio-302347773.html

07 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-oral-presentation-on-oral-glp-2-research-progress-at-the-32nd-united-european-gastroenterology-week-ueg-week-2024-302261785.html

05 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-oral-presentations-at-the-european-association-for-the-study-of-diabetes-60th-annual-meeting-easd-2024-302240167.html

21 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sciwind-biosciences-to-highlight-positive-results-for-injectable-ecnoglutide-phase-3-oral-ecnoglutide-phase-1-and-novel-amylin-analogs-at-the-american-diabetes-association-ada-84th-annual-conference-302178846.html

23 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-positive-results-from-phase-1-clinical-trial-of-xw004-an-oral-formulation-of-long-acting-glp-1-analog-ecnoglutide-302042633.html
ABOUT THIS PAGE